Skip to main navigation Skip to search Skip to main content

Targeted Literature Review of the Burden of Respiratory Syncytial Infection among High-Risk and Elderly Patients in Asia Pacific Region

  • Daisuke Kurai
  • , Joon Young Song
  • , Yhu Chering Huang
  • , Zhijun Jie
  • , Petar Atanasov
  • , Xiaobin Jiang
  • , Luis Hernandez-Pastor
  • , Tom Hsun Wei Huang
  • , Seong Beom Park
  • , Kyung Hwa Lim
  • , Peter C. Richmond*
  • *Corresponding author for this work
  • Kyorin University
  • Korea University
  • Fudan University
  • Amaris Consulting
  • Amaris Consulting
  • Johnson & Johnson
  • Janssen Pharmaceuticals
  • Janssen Pharmaceuticals
  • Asia Pacific Market Access
  • University of Western Australia

Research output: Contribution to journalReview articlepeer-review

23 Scopus citations

Abstract

INTRODUCTION: The burden of respiratory syncytial virus (RSV), which causes acute respiratory illness, is well recognized among the pediatric population but also imposes a significant risk to the elderly (age ≥ 60) and those with underlying comorbidities. The study aimed to review the most recent data on epidemiology and burden (clinical and economic) of RSV in the elderly/high-risk populations in China, Japan, South Korea, Taiwan, and Australia.

METHODS: A targeted review was conducted of English, Japanese, Korean, and Chinese language articles published from 1 January 2010 to 7 October 2020 relevant for the purpose.

RESULTS: A total of 881 studies were identified, and 41 were included. The median proportion of elderly patients with RSV in all adult patients with acute respiratory infection (ARI) or community acquired pneumonia was 79.78% (71.43-88.12%) in Japan, 48.00% (3.64-80.00%) in China, 41.67% (33.33-50.00%) in Taiwan, 38.61% in Australia, and 28.57% (22.76-33.33%) in South Korea. RSV was associated with a high clinical burden on those patients with comorbidities such as asthma and chronic obstructive pulmonary disease. In China, inpatients with ARI showed a significantly higher rate of RSV-related hospitalization than outpatients (13.22% versus 4.08%, p < 0.01). The median length of hospital stay among elderly patients with RSV was longest in Japan (30 days) and shortest in China (7 days). Mortality data varied by region with some studies reporting rates as high as 12.00% (9/75) in hospitalized elderly patients. Finally, data on the economic burden was only available for South Korea, with the median cost of a medical admission for an elderly patient with RSV being US dollar (USD) 2933.

CONCLUSION: RSV infection is a major source of disease burden among elderly patients, especially in regions with aging populations. It also complicates the management of those with underlying diseases. Appropriate prevention strategies are required to reduce the burden among the adult, especially the elderly, population. Data gaps regarding economic burden of RSV infection in the Asia Pacific region indicates the need for further research to increase our understanding on the burden of this disease in this region.

Original languageEnglish
Pages (from-to)807-828
Number of pages22
JournalInfectious Diseases and Therapy
Volume12
Issue number3
DOIs
StatePublished - 03 2023

Bibliographical note

© 2023. The Author(s).

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Acute respiratory infection
  • Asia Pacific
  • Disease burden
  • Economic burden
  • Respiratory syncytial virus

Fingerprint

Dive into the research topics of 'Targeted Literature Review of the Burden of Respiratory Syncytial Infection among High-Risk and Elderly Patients in Asia Pacific Region'. Together they form a unique fingerprint.

Cite this